Neothetics Company Profile (NASDAQ:NEOT)

About Neothetics

Neothetics logoNeothetics, Inc. is a clinical-stage specialty pharmaceutical company, which develops therapeutics. The Company focuses on localized fat reduction and body contouring. It focuses on the development of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese patients. It has completed Phase II development of LIPO-202. LIPO-202 is administered in a subcutaneous injection procedure that activates a natural metabolic process to shrink fat cells, without killing them, resulting in localized fat reduction, measurable results within four weeks and minimal risk with no downtime. The Company is developing a product candidate, LIPO-102, an injectable form of a combination of salmeterol xinafoate and fluticasone propionate. LIPO-102 is indicated for the treatment of the orphan indication of symptomatic exophthalmos, or protrusion of the eye from the orbit, associated with thyroid-related eye disease caused by the expansion of fat and muscle behind the eye.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NEOT
  • CUSIP:
Key Metrics:
  • Previous Close: $1.60
  • 50 Day Moving Average: $1.34
  • 200 Day Moving Average: $1.15
  • 52-Week Range: $0.53 - $1.98
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -3.02
  • P/E Growth: -0.05
  • Market Cap: $22.12M
  • Outstanding Shares: 13,828,000
  • Beta: 2.28
Profitability:
  • Return on Equity: -114.07%
  • Return on Assets: -79.52%
Debt:
  • Current Ratio: 10.40%
  • Quick Ratio: 10.40%
Additional Links:
Companies Related to Neothetics:

Analyst Ratings

Consensus Ratings for Neothetics (NASDAQ:NEOT) (?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for Neothetics (NASDAQ:NEOT)
Show:
DateFirmActionRatingPrice TargetDetails
12/15/2015Piper Jaffray CompaniesDowngradeOverweight -> NeutralView Rating Details
12/15/2015Needham & Company LLCDowngradeBuy -> HoldView Rating Details
11/2/2015GuggenheimReiterated RatingBuy$16.00View Rating Details
(Data available from 2/20/2015 forward)

Earnings

Earnings History for Neothetics (NASDAQ:NEOT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/27/2017        
8/11/2016Q2($0.40)($0.19)ViewN/AView Earnings Details
5/12/2016Q1($0.44)ViewN/AView Earnings Details
3/29/2016Q4($1.14)($0.69)ViewN/AView Earnings Details
11/12/2015Q315($0.84)($1.26)ViewN/AView Earnings Details
8/13/2015Q215($1.14)($0.69)ViewN/AView Earnings Details
5/14/2015Q115($0.93)($0.50)ViewN/AView Earnings Details
3/26/2015Q414($0.32)($0.45)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Neothetics (NASDAQ:NEOT)
Current Year EPS Consensus Estimate: $-1.00 EPS
Next Year EPS Consensus Estimate: $-0.53 EPS

Dividends

Dividend History for Neothetics (NASDAQ:NEOT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Neothetics (NASDAQ:NEOT)
Insider Ownership Percentage: 39.22%
Institutional Ownership Percentage: 11.65%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/30/2015Alta Partners Viii, L.P.InsiderSell797,987$1.51$1,204,960.37View SEC Filing  
12/29/2015Alta Partners Viii, L.P.Major ShareholderSell493,654$1.53$755,290.62View SEC Filing  
12/28/2015Alta Partners Viii, L.P.Major ShareholderSell54,333$1.59$86,389.47View SEC Filing  
12/17/2015Kenneth W. LockeInsiderSell598$1.26$753.48View SEC Filing  
12/17/2015Susan A. KnudsonCFOSell1,005$1.26$1,266.30View SEC Filing  
12/15/2015Alta Partners Viii, L.P.Major ShareholderSell529,261$1.44$762,135.84View SEC Filing  
11/18/2015Kenneth W. LockeinsiderSell6,098$8.30$50,613.40View SEC Filing  
9/18/2015Christopher KemmererVPSell1,000$12.20$12,200.00View SEC Filing  
9/1/2015Susan A. KnudsonCFOSell3,000$11.33$33,990.00View SEC Filing  
3/19/2015George W MahaffeyCEOBuy1,000$7.76$7,760.00View SEC Filing  
11/25/2014Daniel JanneyDirectorSell149,286$14.00$2,090,004.00View SEC Filing  
11/25/2014Rmi Investments S.A.R.L.Major ShareholderBuy70,000$14.00$980,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Neothetics (NASDAQ:NEOT)
DateHeadline
4-traders.com logoNEOTHETICS, INC. (NASDAQ:NEOT) Files An 8-K Entry into a Material Definitive Agreement (NASDAQ:NEOT)
www.4-traders.com - February 14 at 9:26 PM
News IconGraves’ Ophthalmopathy -under Development by Companies, H2 2016 (NASDAQ:NEOT)
empowerednews.net - January 6 at 7:29 PM
streetinsider.com logoForm SC 13G/A Neothetics, Inc. Filed by: DRILL CRAIG A (NASDAQ:NEOT)
www.streetinsider.com - January 6 at 7:29 PM
zacks.com logoNeothetics (NEOT) Begins Phase II Study on Lead Candidate (NASDAQ:NEOT)
www.zacks.com - December 28 at 10:05 AM
einnews.com logoArgentina probes sex abuse at deaf school (NASDAQ:NEOT)
brazilbusiness.einnews.com - December 24 at 6:18 PM
streetinsider.com logoNeothetics (NEOT) Phase 2 Proof of Concept Trial for LIPO-202 Initiated for Double Chin (NASDAQ:NEOT)
www.streetinsider.com - December 24 at 6:18 PM
4-traders.com logoNeothetics : Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat (NASDAQ:NEOT)
www.4-traders.com - December 24 at 6:18 PM
einnews.com logoMarchers seek to make Santa Rosa a sanctuary city (NASDAQ:NEOT)
semiconductors.einnews.com - December 23 at 8:17 PM
einnews.com logoThe Latest: Affidavit details fatal shooting of boy, 3 (NASDAQ:NEOT)
brazilbusiness.einnews.com - December 23 at 8:17 PM
baystreet.ca logoNeothetics (NEOT) Leaped as New Drug Trial Commences (NASDAQ:NEOT)
www.baystreet.ca - December 23 at 8:17 PM
4-traders.com logoNetworkNewsBreaks – Neothetics (NASDAQ: NEOT) Initiates Phase 2 Trial of Fat Reduction Drug; Shares Higher (NASDAQ:NEOT)
www.4-traders.com - December 23 at 8:17 PM
publicnow.com logoNeothetics Initiates Phase 2 Proof of Concept Trial for LIPO-202 for the Reduction of Submental Subcutaneous Fat (NASDAQ:NEOT)
www.publicnow.com - December 23 at 3:15 PM
News IconNeothetics, Inc. NEOT Financial and Strategic SWOT Analysis Review Prices from USD $300 (NASDAQ:NEOT)
www.bioportfolio.com - November 19 at 6:29 PM
einnews.com logoNeothetics Provides Business Update and Reports Third Quarter 2016 Financial Results (NASDAQ:NEOT)
uspolitics.einnews.com - November 10 at 6:09 PM
marketexclusive.com logoNeothetics, Inc. (NASDAQ:NEOT) Files An 8-K Provides Business Update And Reports Third Quarter 2016 Financial Results (NASDAQ:NEOT)
marketexclusive.com - November 10 at 6:09 PM
sg.finance.yahoo.com logoNeothetics reports 3Q loss (NASDAQ:NEOT)
sg.finance.yahoo.com - November 10 at 9:26 AM
einnews.com logoGlobal Industrial Communication Market 2016 Share, Trend, Segmentation and Forecast to 2021 (NASDAQ:NEOT)
it.einnews.com - November 3 at 10:18 AM
einnews.com logoExcel Corporation Closes $25 Million Credit Facility (NASDAQ:NEOT)
automotive.einnews.com - November 3 at 10:18 AM
einnews.com logoGlobal Business Intelligence Market growing at a CAGR of around 8.4% between 2016 and 2021 (NASDAQ:NEOT)
brazilbusiness.einnews.com - November 3 at 10:18 AM
einnews.com logoNuvectra to Present at 7th Annual Craig-Hallum Alpha Select Conference (NASDAQ:NEOT)
world.einnews.com - November 3 at 10:18 AM
einnews.com logoGlobal Greeting Cards Market 2016 Share, Trend, Segmentation and Forecast to 2021 (NASDAQ:NEOT)
uspolitics.einnews.com - November 3 at 10:18 AM
publicnow.com logoNeothetics to Provide a Business Update and Release Third Quarter 2016 Financial Results Thursday, November 10, 2016 (NASDAQ:NEOT)
www.publicnow.com - November 3 at 10:18 AM
4-traders.com logoNEOTHETICS, INC. : Termination of a Material Definitive Agreement (form 8-K) (NASDAQ:NEOT)
www.4-traders.com - September 23 at 5:55 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Termination of a Material Definitive Agreement (NASDAQ:NEOT)
biz.yahoo.com - September 23 at 5:55 PM
live-pr.com logoNew Market Research Report: Neothetics, Inc. (NEOT) - Financial and Strategic SWOT Analysis Review (NASDAQ:NEOT)
www.live-pr.com - August 26 at 9:26 AM
News Icon301 Moved Permanently (NASDAQ:NEOT)
www.biomedreports.com - August 11 at 9:37 AM
nasdaq.com logoNeothetics Provides Business Update and Reports Second Quarter 2016 Financial Results (NASDAQ:NEOT)
www.nasdaq.com - August 11 at 9:37 AM
sg.finance.yahoo.com logoNeothetics reports 2Q loss (NASDAQ:NEOT)
sg.finance.yahoo.com - August 11 at 9:37 AM
publicnow.com logoNeothetics to Provide a Business Update and Release Second Quarter 2016 Financial Results Thursday, August 11, 2016 (NASDAQ:NEOT)
www.publicnow.com - August 4 at 9:37 AM
4-traders.com logoNEOTHETICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K) (NASDAQ:NEOT)
www.4-traders.com - June 19 at 10:23 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Submission of Matters to a Vote of Security Holders (NASDAQ:NEOT)
biz.yahoo.com - June 17 at 8:01 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; (NASDAQ:NEOT)
biz.yahoo.com - June 6 at 8:01 AM
sg.finance.yahoo.com logoNeothetics reports 1Q loss (NASDAQ:NEOT)
sg.finance.yahoo.com - May 12 at 8:13 AM
publicnow.com logoNeothetics Reports First Quarter 2016 Financial Results (NASDAQ:NEOT)
www.publicnow.com - May 12 at 8:07 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits (NASDAQ:NEOT)
biz.yahoo.com - May 12 at 8:01 AM
biz.yahoo.com logoQ1 2016 Neothetics Inc Earnings Release - Before Market Open (NASDAQ:NEOT)
biz.yahoo.com - May 12 at 7:07 AM
publicnow.com logoNeothetics to Release First Quarter 2016 Financial Results (NASDAQ:NEOT)
www.publicnow.com - May 5 at 8:21 AM
finance.yahoo.com logoStocks To Watch: Investors Are Considering These on Monday April 25th (NASDAQ:NEOT)
finance.yahoo.com - April 25 at 11:30 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Change in Directors or Principal (NASDAQ:NEOT)
biz.yahoo.com - February 18 at 4:08 PM
finance.yahoo.com logoNeothetics Announces Leadership Change and Preliminary Update on LIPO-202 (NASDAQ:NEOT)
finance.yahoo.com - February 18 at 4:00 PM
News IconSpeaker: Combining peels with other procedures ‘safe’, easy, inexpensive (NASDAQ:NEOT)
www.healio.com - January 17 at 7:54 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers (NASDAQ:NEOT)
biz.yahoo.com - December 23 at 4:47 PM
247wallst.com logoWhy Neothetics Is Getting Destroyed (NASDAQ:NEOT)
247wallst.com - December 15 at 1:15 PM
finance.yahoo.com logoBreaking: This Biotech Just Got Blown Up on a Late Stage Trial (NASDAQ:NEOT)
finance.yahoo.com - December 14 at 5:54 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:NEOT)
biz.yahoo.com - December 14 at 5:02 PM
noodls.com logoNeothetics Reports LIPO-202 Top-Line Phase 3 Trial Results for the Reduction of Central Abdominal Bulging (NASDAQ:NEOT)
www.noodls.com - December 14 at 4:39 PM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Other Events (NASDAQ:NEOT)
biz.yahoo.com - December 10 at 4:39 PM
finance.yahoo.com logoNEOTHETICS, INC. Financials (NASDAQ:NEOT)
finance.yahoo.com - December 8 at 1:17 PM
noodls.com logoNeothetics Announces Issuance by USPTO of Fourth Patent Directed to LIPO-202 Lead Clinical Asset (NASDAQ:NEOT)
www.noodls.com - December 7 at 8:24 AM
biz.yahoo.com logoNEOTHETICS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (NASDAQ:NEOT)
biz.yahoo.com - December 1 at 5:21 PM

Social

What is Neothetics' stock symbol?

Neothetics trades on the NASDAQ under the ticker symbol "NEOT."

When will Neothetics announce their earnings?

Neothetics is scheduled to release their next quarterly earnings announcement on Monday, March, 27th 2017.

Who owns Neothetics stock?

Neothetics' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Craig A Drill (9.86%). Company insiders that own Neothetics stock include Alta Partners Viii, LP, Christopher Kemmerer, George W Mahaffey, Kenneth W Locke and Susan A Knudson.

How do I buy Neothetics stock?

Shares of Neothetics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Neothetics stock cost?

One share of Neothetics stock can currently be purchased for approximately $1.60.

Neothetics (NASDAQ:NEOT) Chart for Monday, February, 20, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Neothetics (NASDAQ:NEOT)

Earnings History Chart

Earnings by Quarter for Neothetics (NASDAQ:NEOT)

Dividend History Chart

Dividend Payments by Quarter for Neothetics (NASDAQ:NEOT)

Last Updated on 2/20/2017 by MarketBeat.com Staff